[go: up one dir, main page]

BR9812002A - Compostos com efeito antiprimeiro-passe - Google Patents

Compostos com efeito antiprimeiro-passe

Info

Publication number
BR9812002A
BR9812002A BR9812002-6A BR9812002A BR9812002A BR 9812002 A BR9812002 A BR 9812002A BR 9812002 A BR9812002 A BR 9812002A BR 9812002 A BR9812002 A BR 9812002A
Authority
BR
Brazil
Prior art keywords
compounds
pass effect
pass
inhibiting
effect
Prior art date
Application number
BR9812002-6A
Other languages
English (en)
Inventor
James W Harris
Original Assignee
Bioavailability Systems L L C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/997,259 external-priority patent/US6063809A/en
Priority claimed from US09/001,218 external-priority patent/US6124477A/en
Application filed by Bioavailability Systems L L C filed Critical Bioavailability Systems L L C
Publication of BR9812002A publication Critical patent/BR9812002A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Fats And Perfumes (AREA)

Abstract

Patente de Invenção: <B>"COMPOSTOS COM EFEITO ANTIPRIMEIRO-PASSE"<D>. Compostos seguros eficazes para inibição do primeiro-passe e substâncias derivadas de cítricos são proporcionados. Formulações contendo os compostos também são proporcionadas, assim como métodos para seu preparo e para inibição do efeito de primeiro-passe.
BR9812002-6A 1997-08-26 1998-08-26 Compostos com efeito antiprimeiro-passe BR9812002A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5638297P 1997-08-26 1997-08-26
US08/997,259 US6063809A (en) 1997-08-26 1997-12-23 Anti-first-pass effect compounds
US09/001,218 US6124477A (en) 1996-06-27 1997-12-30 Anti-first-pass effect compounds
PCT/US1998/017332 WO1999009976A1 (en) 1997-08-26 1998-08-26 Anti-first-pass effect compounds

Publications (1)

Publication Number Publication Date
BR9812002A true BR9812002A (pt) 2000-09-26

Family

ID=27356877

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9812002-6A BR9812002A (pt) 1997-08-26 1998-08-26 Compostos com efeito antiprimeiro-passe

Country Status (18)

Country Link
EP (1) EP1019042B1 (pt)
JP (1) JP2001526177A (pt)
CN (2) CN1537856A (pt)
AP (1) AP2000001746A0 (pt)
AT (1) ATE238786T1 (pt)
AU (1) AU750224B2 (pt)
BR (1) BR9812002A (pt)
CA (1) CA2299503C (pt)
CZ (1) CZ295411B6 (pt)
DE (1) DE69814118T2 (pt)
DK (1) DK1019042T3 (pt)
ES (1) ES2199457T3 (pt)
IL (1) IL134408A0 (pt)
NZ (1) NZ502767A (pt)
OA (1) OA11398A (pt)
PT (1) PT1019042E (pt)
SI (1) SI1019042T1 (pt)
WO (1) WO1999009976A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1240831A3 (en) * 2001-03-15 2003-06-04 Takasago International Corporation Color fading/discoloration preventive agent
US6752862B2 (en) 2001-03-16 2004-06-22 Takasago International Corporation Color fading/discoloration preventive agent
EP1896075A2 (en) * 2005-06-22 2008-03-12 LifeCycle Pharma A/S Pharmaceutical compositions comprising tacrolimus and a cyp3a4 inhibitor
JP5481746B2 (ja) * 2009-09-28 2014-04-23 公益財団法人東洋食品研究所 フロクマリン類の含有量を低減したイチジクの製造方法
WO2024223797A1 (en) 2023-04-28 2024-10-31 Institut National de la Santé et de la Recherche Médicale Use of cyp3a4 inhibitors for the treatment of hepatitis d virus (hdv) infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2168696B (en) * 1984-12-21 1989-01-11 Boehringer Biochemia Srl Fluoro coumarins as antilymphoedema agents

Also Published As

Publication number Publication date
CN1270519A (zh) 2000-10-18
OA11398A (en) 2004-04-14
CN1537856A (zh) 2004-10-20
AP2000001746A0 (en) 2000-03-31
EP1019042A1 (en) 2000-07-19
JP2001526177A (ja) 2001-12-18
SI1019042T1 (en) 2003-12-31
DK1019042T3 (da) 2003-08-25
PT1019042E (pt) 2003-09-30
NZ502767A (en) 2001-11-30
ATE238786T1 (de) 2003-05-15
ES2199457T3 (es) 2004-02-16
DE69814118T2 (de) 2004-04-01
EP1019042B1 (en) 2003-05-02
DE69814118D1 (en) 2003-06-05
CA2299503A1 (en) 1999-03-04
IL134408A0 (en) 2001-04-30
CZ2000695A3 (cs) 2000-08-16
CZ295411B6 (cs) 2005-08-17
WO1999009976A1 (en) 1999-03-04
AU9028898A (en) 1999-03-16
CN1155377C (zh) 2004-06-30
CA2299503C (en) 2006-08-22
AU750224B2 (en) 2002-07-11
EP1019042A4 (en) 2001-07-11

Similar Documents

Publication Publication Date Title
ATE231872T1 (de) Thiazolopyrimidinderivate
TR200001203T2 (tr) Yeni birleşik maddeler
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
BR0009830A (pt) Composições para cuidados com a pele contendo uma combinação de substâncias ativas para cuidados com a pele
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
EE05183B1 (et) Asabitsklilised hendid, nende valmistamine ja kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon
DZ3191A1 (fr) Composés d&#39;indazole et compositions pharmaceutiques inhibant les protéines kinases, et procédés d&#39;utilisation de ceux-ci.
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
MA26548A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol.
SE9704546D0 (sv) Novel compounds
CO4910133A1 (es) Antagonistas de 5-h[1f]
TR200100054T2 (tr) Paroksetin metansülfonat
AP1424A (en) 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
TR200000152T2 (tr) Yeni bileşikler.
BR9909486A (pt) Compostos calcilìticos
SE9802937D0 (sv) Novel compounds
BR9809495A (pt) &#34;maleimidas aromáticas e métodos para seus usos&#34;
EE9900450A (et) Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
BR9709406B1 (pt) fluorenonas alquiloxiamino substituìdas e composição farmacêutica contendo as mesmas.
BR9812002A (pt) Compostos com efeito antiprimeiro-passe
PL340459A1 (en) Agonists of 5ht1f
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
NO20020914L (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
BR0017046A (pt) Uso de azóis para prevenção de câncer de pele

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE PATENTE COM BASE NOS ARTIGOS 8O, 13, 10 ( VIII ) E 25 DA LPI NO 9279 DE 14/05/1996